VTVT · vTv Therapeutics Inc
United States · RS rating 21 · As of 2026-11-03
| Price | 23.55 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 19 / 19 / 59 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 10 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +46.3% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +44.9% |
| Market cap (USD) | $137.3M |